Skip to main content

Advertisement

Table 2 Associations of relative leukocyte telomere length (LTL) with proliferative diagnoses

From: Leukocyte telomere length and its association with mammographic density and proliferative diagnosis among women undergoing diagnostic image-guided breast biopsy

  Women with proliferative diagnosis1 (N = 141) Mean (SD) Women with non-proliferative diagnosis2 (N = 54) Mean (SD) OR (95 % CI)* OR (95 % CI)**
Relative LTL 1.6 (0.9) 1.2 (0.6) 2.46 (1.47, 4.42) 2.41 (1.43, 4.38)
  Women with in situ or invasive cancer diagnosis (N = 31) Mean (SD) Women with non-proliferative diagnosis2 (N = 54) Mean (SD)   
Relative LTL 1.7 (1.1) 1.2 (0.6) 1.98 (1.07, 4.14) 1.70 (0.86, 3.76)
  1. SD Standard deviation
  2. 1Diagnosis of hyperplasia, in-situ or invasive carcinomas
  3. 2Diagnosis of benign or other discrete non-proliferative diagnosis
  4. *Adjusted for age (continuous) and BMI (continuous)
  5. **Adjusted for age (continuous), BMI (continuous), age at first birth (nulliparous/<30/≥30) and menopausal hormone therapy (premenopausal/postmenopausal ever/ postmenopausal never)